Dr. Roland D. Türk
Angestellt, Business Unit Director, Hematology & Oncology, Bristol Myers Squibb
Zürich, Schweiz
Werdegang
Berufserfahrung von Roland D. Türk
Bis heute 2 Jahre und 7 Monate, seit Okt. 2021
Business Unit Director, Hematology & Oncology
Bristol Myers Squibb
Multiple myeloma, lymphoma, myelofibrosis, AML, CML, MDS, CAR T therapies, immuno-oncology, lung cancer, renal carcinoma, melanoma, gastric cancer, bladder cancer, mesothelioma
8 Monate, Feb. 2021 - Sep. 2021
Business Unit Director, Hematology
Celgene
Multiple Myeloma, Lymphoma, Myelofibrosis, AML, CML, MDS, CAR T therapies
1 Jahr und 11 Monate, März 2019 - Jan. 2021
Marketing Lead Hematology & Oncology
Celgene GmbH
Direct and matrix leadership Multiple Myeloma (MM) Lymphoma Myelodysplastic syndrome (MDS) Acute Myeloid Leukemia (AML) Myelofibrosis (MF)
2 Jahre und 1 Monat, Feb. 2017 - Feb. 2019
Senior Product Manager Hematology / Workstream Lead rrMM & ndMM Maintenance
Celgene GmbH
Product manager Multiple Myeloma: Revlimid & Imnovid Direct people management responsibility
2 Jahre, März 2015 - Feb. 2017
Product Manager Oncology / Disease Team Lead Solid Tumors
Celgene
Disease Team Lead for solid tumors Product Manager Oncology: Abraxane in pancreatic cancer, breast cancer and non-small cell lung cancer
2 Jahre, März 2013 - Feb. 2015
Product Manager Cardiovascular
Bristol-Myers Squibb SA
3 Jahre, Apr. 2010 - März 2013
Scientific Advisor Immunoscience
Bristol-Myers Squibb SA
1 Jahr und 1 Monat, Apr. 2009 - Apr. 2010
Medical Science Manager / Disease Area Specialist Immunoscience
Bristol-Myers Squibb SA
Ausbildung von Roland D. Türk
1 Jahr und 7 Monate, Okt. 2011 - Apr. 2013
BAS in General Management
European Business School Zurich
General Management, Marketing and Public Relations, Process Management, Project Management, Organizational Development, Procurement and Logistics, Quality Management / Environmental Management /Security Management, Leadership and HR Management, Accounting & Finance, IT
1 Monat, Nov. 2007 - Nov. 2007
Christian de Duve Institute of Cellular Pathology, UCL Brussels
LC-ESI mass spectrometry, post translational modifications
1 Monat, Feb. 2004 - Feb. 2004
MRC Clinical Sciences Centre, Imperial College, London
Purification of oligomeric kinases from tissue
4 Jahre und 4 Monate, Apr. 2003 - Juli 2007
Energy metabolism, diabetes type II, fatty acid metabolism
ETH Zurich, PhD Student
Cellular signaling, biochemistry, molecular biology, mass spectrometry, proteomics, post-translational modifications
4 Jahre und 7 Monate, Okt. 1998 - Apr. 2003
Biology
ETH Zurich, Switzerland
Molecular genetics, immunology, cell biology, biochemistry, biotechnology
Sprachen
Deutsch
Muttersprache
Englisch
Fließend
Französisch
Gut